BE1006819A7 - Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen. - Google Patents

Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen. Download PDF

Info

Publication number: BE1006819A7
Authority: BE; Belgium
Prior art keywords: prostheses; treatment; vessel; stents; chokes
Prior art date: 1993-03-24

Application number

BE9300285A

Other languages

English (en)

Dutch (nl)

Original Assignee

Dsb Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-24

Filing date

1993-03-24

Publication date

1994-12-13

1993-03-24 Application filed by Dsb Nv filed Critical Dsb Nv

1993-03-24 Priority to BE9300285A priority Critical patent/BE1006819A7/nl

1994-03-24 Priority to AU61780/94A priority patent/AU6178094A/en

1994-03-24 Priority to PCT/BE1994/000024 priority patent/WO1994021309A1/fr

1994-12-13 Application granted granted Critical

1994-12-13 Publication of BE1006819A7 publication Critical patent/BE1006819A7/nl

Links

229920002635 polyurethane Polymers 0.000 title claims abstract description 11
239000004814 polyurethane Substances 0.000 title claims abstract description 11
210000004204 blood vessel Anatomy 0.000 claims abstract description 11
239000011248 coating agent Substances 0.000 claims abstract description 5
238000000576 coating method Methods 0.000 claims abstract description 5
230000004044 response Effects 0.000 claims abstract description 3
238000000034 method Methods 0.000 claims description 10
208000031481 Pathologic Constriction Diseases 0.000 claims description 5
241001465754 Metazoa Species 0.000 abstract description 5
229940079593 drug Drugs 0.000 abstract description 5
239000003814 drug Substances 0.000 abstract description 5
229920000642 polymer Polymers 0.000 abstract description 3
239000008280 blood Substances 0.000 abstract description 2
210000004369 blood Anatomy 0.000 abstract description 2
238000002513 implantation Methods 0.000 abstract description 2
230000028709 inflammatory response Effects 0.000 abstract description 2
150000002009 diols Chemical class 0.000 description 3
239000002184 metal Substances 0.000 description 3
208000037803 restenosis Diseases 0.000 description 3
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
230000001732 thrombotic effect Effects 0.000 description 2
PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
239000005541 ACE inhibitor Substances 0.000 description 1
208000020446 Cardiac disease Diseases 0.000 description 1
239000004970 Chain extender Substances 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
102000007625 Hirudins Human genes 0.000 description 1
108010007267 Hirudins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
108010023197 Streptokinase Proteins 0.000 description 1
239000004433 Thermoplastic polyurethane Substances 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
230000002927 anti-mitotic effect Effects 0.000 description 1
239000003080 antimitotic agent Substances 0.000 description 1
CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
229940006607 hirudin Drugs 0.000 description 1
230000003463 hyperproliferative effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
229960002437 lanreotide Drugs 0.000 description 1
108010021336 lanreotide Proteins 0.000 description 1
230000002107 myocardial effect Effects 0.000 description 1
229960005202 streptokinase Drugs 0.000 description 1
229920002803 thermoplastic polyurethane Polymers 0.000 description 1
230000002885 thrombogenetic effect Effects 0.000 description 1
230000002792 vascular Effects 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Materials For Medical Uses (AREA)
Media Introduction/Drainage Providing Device (AREA)

BE9300285A 1993-03-24 1993-03-24 Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen. BE1006819A7 (nl)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
BE9300285A BE1006819A7 (nl)	1993-03-24	1993-03-24	Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen.
AU61780/94A AU6178094A (en)	1993-03-24	1994-03-24	Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
PCT/BE1994/000024 WO1994021309A1 (fr)	1993-03-24	1994-03-24	Protheses intravasculaires (extenseurs) enrobees de polyurethanne et destinees au traitement de la stenose des vaisseaux sanguins

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
BE9300285A BE1006819A7 (nl)	1993-03-24	1993-03-24	Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen.

Publications (1)

Publication Number	Publication Date
BE1006819A7 true BE1006819A7 (nl)	1994-12-13

Family

ID=3886925

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE9300285A BE1006819A7 (nl)	1993-03-24	1993-03-24	Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen.

Country Status (3)

Country	Link
AU (1)	AU6178094A (fr)
BE (1)	BE1006819A7 (fr)
WO (1)	WO1994021309A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6099562A (en) *	1996-06-13	2000-08-08	Schneider (Usa) Inc.	Drug coating with topcoat
US6120536A (en) *	1995-04-19	2000-09-19	Schneider (Usa) Inc.	Medical devices with long term non-thrombogenic coatings
US5837313A (en) *	1995-04-19	1998-11-17	Schneider (Usa) Inc	Drug release stent coating process
US5980972A (en) *	1996-12-20	1999-11-09	Schneider (Usa) Inc	Method of applying drug-release coatings
US6273913B1 (en)	1997-04-18	2001-08-14	Cordis Corporation	Modified stent useful for delivery of drugs along stent strut
ATE466603T1 (de)	1998-04-27	2010-05-15	Surmodics Inc	Bioaktive wirkstoffe freisetzende beschichtungen
US6776796B2 (en)	2000-05-12	2004-08-17	Cordis Corportation	Antiinflammatory drug and delivery device
US7300662B2 (en)	2000-05-12	2007-11-27	Cordis Corporation	Drug/drug delivery systems for the prevention and treatment of vascular disease
US8236048B2 (en)	2000-05-12	2012-08-07	Cordis Corporation	Drug/drug delivery systems for the prevention and treatment of vascular disease
AU9486901A (en)	2000-09-29	2002-04-08	Cordis Corp	Coated medical devices
US20020111590A1 (en)	2000-09-29	2002-08-15	Davila Luis A.	Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US7261735B2 (en)	2001-05-07	2007-08-28	Cordis Corporation	Local drug delivery devices and methods for maintaining the drug coatings thereon
GB0100761D0 (en)	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
US8182527B2 (en)	2001-05-07	2012-05-22	Cordis Corporation	Heparin barrier coating for controlled drug release
US7195640B2 (en)	2001-09-25	2007-03-27	Cordis Corporation	Coated medical devices for the treatment of vulnerable plaque
US7108701B2 (en)	2001-09-28	2006-09-19	Ethicon, Inc.	Drug releasing anastomosis devices and methods for treating anastomotic sites
US7097850B2 (en)	2002-06-18	2006-08-29	Surmodics, Inc.	Bioactive agent release coating and controlled humidity method
US7541048B2 (en)	2004-04-06	2009-06-02	Surmodics, Inc.	Coating compositions for bioactive agents
US20060088571A1 (en) *	2004-10-21	2006-04-27	Medtronic Vascular, Inc.	Biocompatible and hemocompatible polymer compositions
US9827401B2 (en)	2012-06-01	2017-11-28	Surmodics, Inc.	Apparatus and methods for coating medical devices
MX351261B (es)	2012-06-01	2017-10-06	Surmodics Inc	Aparato y método para recubrir catéteres con globo.
DE102014201889A1 (de)	2014-02-03	2015-08-20	Aesculap Ag	Medizinisches Produkt zur Anwendung bei der Behandlung von Hernien
US11628466B2 (en)	2018-11-29	2023-04-18	Surmodics, Inc.	Apparatus and methods for coating medical devices
US11819590B2 (en)	2019-05-13	2023-11-21	Surmodics, Inc.	Apparatus and methods for coating medical devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS588700B2 (ja) *	1980-09-12	1983-02-17	工業技術院長	抗血栓性高弾性ポリウレタン化合物の製造方法
EP0257091B1 (fr) *	1986-02-24	1993-07-28	Robert E. Fischell	Distendeur intravasculaire et systeme d'introduction percutanee
US5449372A (en) *	1990-10-09	1995-09-12	Scimed Lifesystems, Inc.	Temporary stent and methods for use and manufacture
AU1579092A (en) *	1991-02-27	1992-10-06	Nova Pharmaceutical Corporation	Anti-infective and anti-inflammatory releasing systems for medical devices
EP0566245B1 (fr) *	1992-03-19	1999-10-06	Medtronic, Inc.	Dilatateur intraluminal

1993
- 1993-03-24 BE BE9300285A patent/BE1006819A7/nl not_active IP Right Cessation
1994
- 1994-03-24 AU AU61780/94A patent/AU6178094A/en not_active Abandoned
- 1994-03-24 WO PCT/BE1994/000024 patent/WO1994021309A1/fr not_active Ceased

Also Published As

Publication number	Publication date
AU6178094A (en)	1994-10-11
WO1994021309A1 (fr)	1994-09-29

Publication	Publication Date	Title
BE1006819A7 (nl)	1994-12-13	Polyurethaan gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen.
BE1008260A6 (nl)	1996-02-27	Amfifiele polyurethanen opgeladen met medicijnen gecoat op vasculaire stents ter behandeling van bloedvatvernauwingen.
Wache et al.	2003	Development of a polymer stent with shape memory effect as a drug delivery system
Liermann et al.	1992	The Strecker stent: indications and results in iliac and femoropopliteal arteries
US6203536B1 (en)	2001-03-20	Medical device for delivering a therapeutic substance and method therefor
Ozaki et al.	1996	New stent technologies
US20050049691A1 (en)	2005-03-03	Polymeric reconstrainable, repositionable, detachable, percutaneous endovascular stentgraft
WO1998057706A1 (fr)	1998-12-23	Dispositif implantable d'administration d'un rayonnement localise in vivo et son procede de production
Tsuji et al.	2001	Biodegradable polymeric stents
JP2009525809A (ja)	2009-07-16	表面浸食性ポリエステルによる薬剤送達コーティングを備える埋め込み式医療デバイス
EP0691841B1 (fr)	2002-05-29	Extenseurs a liberation de medicaments
WO2002069842A2 (fr)	2002-09-12	Appareil et methode permettant de maintenir la circulation dans un vaisseau ou un canal
JP2006500996A (ja)	2006-01-12	溶出性生体適合性移植可能医療器具を介してマイトマイシンを送達するための装置および方法
US6746481B1 (en)	2004-06-08	Implatable device including a polyamino acid component
Ellis et al.	1989	Intracoronary stents: will they fulfill their promise as an adjunct to angioplasty?
De Scheerder et al.	2001	Intravascular low‐power laser irradiation after coronary stenting: Long‐term follow‐up
De Scheerder et al.	1996	Concept of the homemade coronary stent: experimental results and initial clinical experience
McKenna et al.	1997	Novel stents for the prevention of restenosis
BE1006816A7 (nl)	1994-12-13	Polyphosfazeen-gecoate prothesen (stents) voor de behandeling van bloedvatvernauwingen.
Oyamada et al.	2011	Trans-iliac rat aorta stenting: a novel high throughput preclinical stent model for restenosis and thrombosis
De Feyter et al.	1996	Some thoughts on the present and future of coronary artery stenting
BE1008668A6 (nl)	1996-07-02	Een nieuwe endovasculaire prothese (ids-sts-2) ter behandeling van gedissecteerde en vernauwde bloedvaten.
US20090228097A1 (en)	2009-09-10	A1 Adenosine Receptor Antagonist-Coated Implantable Medical Device
Fajadet et al.	1992	Coronary Stenting with the Palmaz-Schatz Stent: The Clinic Pasteur Interventional Cardiology Unit Experience
EP1847279B1 (fr)	2009-01-28	Administration de médicaments via un film conforme

Legal Events

Date	Code	Title	Description
1995-09-30	RE	Patent lapsed	Owner name: DSB N.V. Effective date: 19950331

Date

Code

Title

Description

1995-09-30

Patent lapsed

Owner name: DSB N.V.

Effective date: 19950331